Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2390812, 5 pages
https://doi.org/10.1155/2017/2390812
Research Article

Thyroid Dysfunction in Non-Interferon Treated Hepatitis C Patients Residing in Hepatitis Endemic Area

1Institute of Chemistry, New Campus, University of the Punjab, Lahore, Pakistan
2Centre for Nuclear Medicine (CENUM), P.O. Box No. 53, Mayo Hospital, Lahore, Pakistan

Correspondence should be addressed to Nayab Batool; moc.liamg@ivzir.bayan

Received 15 November 2016; Revised 20 April 2017; Accepted 26 April 2017; Published 30 May 2017

Academic Editor: Yujiang Fang

Copyright © 2017 Nayab Batool et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Waheed, U. Saeed, S. Anjum, M. S. Afzal, and M. Ashraf, “Development of global consensus sequence and analysis of highly conserved domains of the HCV NS5B protein,” Hepatitis Monthly, vol. 12, no. 9, Article ID e6142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. K. Shaikh, J. A. Samo, B. R. Devrajani, and S. Z. A. Shah, “Extra hepatic manifestations of patients with chronic hepatitis C,” World Applied Sciences Journal, vol. 20, no. 6, pp. 812–817, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Tomer, “Hepatitis C and interferon induced thyroiditis,” Journal of Autoimmunity, vol. 34, no. 3, pp. J322–J326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Waheed, “Effect of interferon plus ribavirin therapy on hepatitis C virus genotype 3 patients from Pakistan: treatment response, side effects and future prospective,” Asian Pacific Journal of Tropical Medicine, vol. 8, no. 2, pp. 85–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. D. L. Ward and R. G. Bing-You, “Autoimmune thyroid dysfunction induced by interferon-alfa treatment for chronic hepatitis C: screening and monitoring recommendations,” Endocrine Practice, vol. 7, no. 1, pp. 52–58, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Marazuela, L. García-Buey, B. González-Fernández et al., “Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-α therapy,” Clinical Endocrinology, vol. 44, no. 6, pp. 635–642, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Ganne-Carrie, A. Medini, E. Coderc et al., “Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study,” Journal of Autoimmunity, vol. 14, no. 2, pp. 189–193, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. D. V. Stefanova-Petrova, A. H. Tzvetanska, E. J. Naumova et al., “Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients,” World Journal of Gastroenterology, vol. 13, no. 48, pp. 6518–6528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Akeno, J. T. Blackard, and Y. Tomer, “HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity,” Journal of Autoimmunity, vol. 31, no. 4, pp. 339–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. T. Blackard, L. Kong, A. K. Huber, and Y. Tomer, “Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis,” Thyroid, vol. 23, no. 7, pp. 863–870, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Bartolomé, E. Rodríguez-Iñigo, P. Quadros et al., “Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection,” Journal of Medical Virology, vol. 80, no. 9, pp. 1588–1594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Nadeem, M. M. Hussain, M. Aslam, and T. Hussain, “Interferon-alpha induced and ribavirin induced thyroid dysfunction in patients with chronic hepatitis C,” Hepatitis Monthly, vol. 10, no. 2, pp. 132–140, 2010. View at Google Scholar · View at Scopus
  13. B. Salim, M. Khurram, S. I. Gilani, K. Ejaz, M. Arif, and H. B. Khaar, “Thyroid function abnormalities in chronic hepatitis C patients treated with standard interferon and ribavirin at three months after starting treatment,” Pakistan Journal of Gastroenterology, vol. 22, no. 1, pp. 28–31, 2008. View at Google Scholar
  14. M. A. Saeed, M. Sadiq, A. Zulfiqar, J. Irfan, and S. Jalali, “Thyroid disorders in hepatitis C virus infected untreated patients,” Journal of Rawalpindi Medical College, vol. 13, no. 2, pp. 60–62, 2009. View at Google Scholar
  15. M. Imran, K. Kammeruddin, and N. Sajid, “Frequency of thyroid dysfunction in chronic hepatitis C sero positives,” Pakistan Medicine and Dentistry, vol. 5, no. 1, pp. 25–27, 2016. View at Google Scholar
  16. M. I. Shafiq, A. Gauhar, M. Akram, and S. Elahi, “Thyroid peroxidase antibodies in non-interferon treated hepatitis C patients in Pakistan,” BioMed Research International, vol. 2015, Article ID 172981, 5 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Shao, N. Huo, L. Zhao et al., “The presence of thyroid peroxidase antibody of IgG2 subclass is a risk factor for thyroid dysfunction in chronic hepatitis C patients,” European Journal of Endocrinology, vol. 168, no. 5, pp. 717–722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. M. Ferrari, P. Fallahi, A. Antonelli, and S. Benvenga, “Environmental issues in thyroid diseases,” Frontiers in Endocrinology, vol. 8, 2017. View at Publisher · View at Google Scholar
  19. J. G. Hollowell, N. W. Staehling, W. Dana Flanders et al., “Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III),” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 489–499, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Lucas, M. T. Julián, A. Cantón et al., “Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population,” Endocrine, vol. 38, no. 3, pp. 391–396, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Shen, X. Wang, J. Xie et al., “Thyroid disturbance in patients with chronic hepatitis C infection: a systematic review and meta-analysis,” Journal of Gastrointestinal and Liver Diseases, vol. 25, no. 2, pp. 227–234, 2016. View at Google Scholar
  22. L. A. Salazar, X. Garcia-Samper, R. Suarez-Carpio et al., “Hypothyroidism in noninterferon treated-HCV infected individuals is associated with abnormalities in the regulation of Th17 Cells,” Hepatitis Research and Treatment, vol. 2010, Article ID 971095, 6 pages, 2010. View at Publisher · View at Google Scholar
  23. G. Indolfi, S. Stagi, E. Bartolini et al., “Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection,” Clinical Endocrinology, vol. 68, no. 1, pp. 117–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Testa, P. Castaldi, V. Fant et al., “Prevalence of HCV antibodies in autoimmune thyroid disease,” European Review for Medical and Pharmacological Sciences, vol. 10, no. 4, pp. 183–186, 2006. View at Google Scholar · View at Scopus
  25. H. G. Hass, R. Klein, O. Nehls, and S. Kaiser, “Thyroid disorders and occurrence of Nonorgan-Specific Autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1),” Journal of Clinical Gastroenterology, vol. 43, no. 5, pp. 470–476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Muratori, D. P. Bogdanos, P. Muratori et al., “Susceptibility to thyroid disorders in hepatitis C,” Clinical Gastroenterology and Hepatology, vol. 3, no. 6, pp. 595–603, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M.-J. Huang, S.-L. Tsai, B.-Y. Huang, I.-S. Sheen, C.-T. Yeh, and Y.-F. Liaw, “Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study,” Clinical Endocrinology, vol. 50, no. 4, pp. 503–509, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. X.-R. Mao, L.-T. Zhang, H. Chen, P. Xiao, and Y.-C. Zhang, “Possible factors affecting thyroid dysfunction in hepatitis C virus-infected untreated patients,” Experimental and Therapeutic Medicine, vol. 8, no. 1, pp. 133–140, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Tawfik and A. El-Sawy, “Low serum free and total tri-iodothyronine hormones as possible prognostic factors in liver cirrhotic patients because of chronic hepatitis C,” Tanta Medical Journal, vol. 43, no. 2, pp. 46–51, 2015. View at Publisher · View at Google Scholar
  30. M. A. El-Feki, N. H. Abdalla, M. I. Atta, and A. A. Ibrahim, “Serum level of thyroid hormones in patients with chronic hepatitis C virus infection,” Open Journal of Endocrine and Metabolic Diseases, vol. 6, no. 3, pp. 126–134, 2016. View at Publisher · View at Google Scholar
  31. N. Masood, R. Ghori, A. Memon et al., “Frequency of thyroid disorders during interferon and ribavirin therapy in chronic hepatitis C infection,” Journal of the College of Physicians and Surgeons Pakistan, vol. 18, no. 6, pp. 347–351, 2008. View at Google Scholar · View at Scopus